418 — Albany, New York

418 is a clinical research site located in Albany, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

418 has participated in 1 clinical trials.

Therapeutic areas: Early Stage Parkinson Disease.

Sponsors: Solvay Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 418?

418 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 418 conducted?

418 has 1 clinical trials on record. Their work covers Early Stage Parkinson Disease.

Is 418 accredited by Crixeo Health?

418 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 418?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.